SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/14/17 Emmaus Life Sciences, Inc. 10-Q 6/30/17 52:5.4M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 473K 2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 123K 3: EX-4.9 Instrument Defining the Rights of Security Holders HTML 137K 4: EX-10.30 Material Contract HTML 35K 5: EX-31.1 Certification -- §302 - SOA'02 HTML 20K 6: EX-31.2 Certification -- §302 - SOA'02 HTML 20K 7: EX-32.1 Certification -- §906 - SOA'02 HTML 17K 14: R1 Document and Entity Information HTML 42K 15: R2 Unaudited Condensed Consolidated Statements of HTML 68K Operations 16: R3 Unaudited Condensed Consolidated Balance Sheets HTML 101K 17: R4 Unaudited Condensed Consolidated Balance Sheets HTML 38K (Parenthetical) 18: R5 Unaudited Condensed Consolidated Statements of HTML 103K Cash Flows 19: R6 Unaudited Condensed Consolidated Statements of HTML 57K Stockholders' Deficit 20: R7 Nature of Operations HTML 44K 21: R8 Summary of Significant Accounting Policies HTML 62K 22: R9 Stockholders' Equity HTML 151K 23: R10 Prior Year Revision HTML 35K 24: R11 Related Party Transactions HTML 55K 25: R12 Loss Per Share HTML 42K 26: R13 Commitments and Contingent Liabilities HTML 36K 27: R14 Subsequent Events HTML 30K 28: R15 Summary of Significant Accounting Policies HTML 122K (Policies) 29: R16 Stockholders' Equity (Tables) HTML 113K 30: R17 Prior Year Revision (Tables) HTML 32K 31: R18 Related Party Transactions (Tables) HTML 36K 32: R19 Loss Per Share (Tables) HTML 41K 33: R20 Commitments and Contingent Liabilities (Tables) HTML 30K 34: R21 Nature of Operations (Details Narrative) HTML 90K 35: R22 Summary of Significant Accounting Policies HTML 72K (Details Narrative) 36: R23 Stockholders' Equity (Details) HTML 25K 37: R24 Stockholders' Equity (Details 1) HTML 39K 38: R25 Stockholders' Equity (Details 2) HTML 115K 39: R26 Stockholders' Equity (Details 3) HTML 39K 40: R27 Stockholders' Equity (Details 4) HTML 46K 41: R28 Stockholders' Equity (Details Narrative) HTML 491K 42: R29 Stockholders' Equity (Details Narrative 1) HTML 46K 43: R30 Prior Year Revision (Details) HTML 25K 44: R31 Related Party Transactions (Details) HTML 50K 45: R32 Related Party Transactions (Details Narrative) HTML 119K 46: R33 Loss Per Share (Details) HTML 36K 47: R34 Commitments and Contingent Liabilities (Details) HTML 52K 48: R35 Commitments and Contingent Liabilities (Details HTML 51K Narrative) 49: R36 Subsequent Events (Details Narrative) HTML 89K 51: XML IDEA XML File -- Filing Summary XML 84K 50: EXCEL IDEA Workbook of Financial Reports XLSX 79K 8: EX-101.INS XBRL Instance -- myan-20170630 XML 1.58M 10: EX-101.CAL XBRL Calculations -- myan-20170630_cal XML 120K 11: EX-101.DEF XBRL Definitions -- myan-20170630_def XML 549K 12: EX-101.LAB XBRL Labels -- myan-20170630_lab XML 924K 13: EX-101.PRE XBRL Presentations -- myan-20170630_pre XML 731K 9: EX-101.SCH XBRL Schema -- myan-20170630 XSD 131K 52: ZIP XBRL Zipped Folder -- 0001615774-17-004413-xbrl Zip 131K
Download this zipped .zip folder | |
Files: | myan-20170630.xml myan-20170630.xsd myan-20170630_cal.xml myan-20170630_def.xml myan-20170630_lab.xml myan-20170630_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/22 Emmaus Life Sciences, Inc. 10-K 12/31/21 98:18M ActiveDisclosure/FA 8/10/21 Emmaus Life Sciences, Inc. 10-K/A 12/31/20 92:18M ActiveDisclosure/FA |